The 2018 Bentley Global Business Ethics Symposium is presented by The Bentley Alliance for Ethics and Social Responsibility and the Gloria Cordes Larson Center for Women and Business in partnership with the State Street Foundation. This year's event is focused on the “Ethics of Inclusion”.
You are here
TOPIC: Academic Fusion
Bentley University announced changes in its academic leadership team to position the university for continued success, including the appointment of Rick Oches, chair of the department of natural and applied sciences, to new dean of arts and sciences.
Massachusetts Congresswoman Katherine Clark and biotechnology industry leaders recently visited Bentley for a conversation about the essential role of government in funding basic biomedical science and how companies use this science to create new medicines, jobs and successful companies.
When Brenden Botelho ‘20 and Jonny Boains ‘18 took internships in the Mass. Office of Energy and Environmental Affairs, what was the biggest community problem to tackle? Adapting to climate change.
A president's legacy of genuine leadership.
The Association for Information Systems (AIS) presented Bentley’s Jane Fedorowicz with the Sandra Slaughter Service Award, during a ceremony at the 2017 International Conference on Information Systems.
A study from Bentley's Center for Integration of Science and Industry published makes a strong case for public funding of research. Center Director Dr. Fred Ledley comments on the significance of these findings.
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study from the Center for Integration of Science and Industry.
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.
A recent published study from Bentley's Center for Integration of Science and Industry shows that the thirty year path from the initiation of research on oligonucleotides as therapeutics to the emergence of effective products followed predictable patterns of innovation, in which novel products are successfully developed only after the underlying basic research reaches a requisite level of maturity.